MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0142146
Ripharma Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.14 Cr
▲ 146% YoY
Net profit · FY 2025
₹6.03 Cr
Net margin 8.8%
EBITDA · FY 2025
₹58.87 Cr
EBITDA margin 86.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹4.9 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
6
As per MCA filings
About Ripharma Laboratories Limited
Data last updated:
Ripharma Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2015PLC262970. Its GSTIN is 27AAHCR2686R1ZF (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rishabh Shreepal Jain and Shantilal Rajmal Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 144 Behram Mahal 534 Kalbadevi Road Near Edward Cinema, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.14 Cr, a growth of 146% compared to the previous year. For the same year it recorded a net profit of ₹6.03 Cr (net margin 8.8%) and EBITDA of ₹58.87 Cr (EBITDA margin 86.4%).
The company is associated with 1 brand: Ripharma. As per MCA filings, the company has open charges of ₹4.9 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 6 cases are pending.
Ripharma Laboratories Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0142146). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ripharma.in.
Company details
CIN U24100MH2015PLC262970
Registration Number 262970
Incorporation Date 25 March 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0142146
Key People
Rishabh Shreepal Jain Director Shantilal Rajmal Jain Director Shreepal Champalal Jain Director Recognitions & Rankings of Ripharma Laboratories
Contact details
Ripharma Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is ripharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address144 Behram Mahal 534 Kalbadevi Road Near Edward Cinema, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ripharma Laboratories Limited, buy the company report.
Comprehensive company report
Ripharma Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ripharma Laboratories operates one associated brand: Ripharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical discovery, development, and delivery in India. | ripharma.in |
Business activity
The main business activity of Ripharma Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ripharma Laboratories Limited, buy the company report.
Financials of Ripharma Laboratories Limited
FY 2025 filings availableRipharma Laboratories Limited reported revenue of ₹68.14 Cr (up 146% YoY) for FY 2025.
Revenue · FY 2025
₹68.14 Cr ▲ 146%
Net profit · FY 2025
₹6.03 Cr margin 8.8%
EBITDA · FY 2025
₹58.87 Cr margin 86.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 146%
Revenue rose 146% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹68.14 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 86.4% | ||||
| Net Profit Margin | 8.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ripharma Laboratories Limited, buy the company report.
Board of directors of Ripharma Laboratories Limited
Ripharma Laboratories has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Shreepal Jain | Director | 25 Mar 2015 | 11 Years 7 Months | Current |
| Shantilal Rajmal Jain Also directs: Raja-Nava Developers Pvt Ltd, Skyline Construtech Private Limited | Director | 04 Feb 2025 | 1 Years 9 Months | Current |
| Shreepal Champalal Jain Also directs: Skyline Construtech Private Limited, Rishabh Indotex Limited | Director | 25 Mar 2015 | 11 Years 7 Months | Current |
| Shrenik Champalal Jain Also directs: Skyline Construtech Private Limited, Rishabh Indotex Limited | Director | 25 Mar 2015 | 11 Years 7 Months | Current |
| Milan Champalal Jain Also directs: Skyline Construtech Private Limited, Rishabh Indotex Limited | Director | 25 Mar 2015 | 11 Years 7 Months | Current |
| Amit Shantilal Jain | Director | 25 Mar 2015 | 11 Years 7 Months | Current |
Auditor
Ripharma Laboratories Limited is audited by NPV & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NPV & Associates LLP | FY 2024 | 129408W/W100982 |
Shareholding
The shareholding of Ripharma Laboratories Limited is on record for 4 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ripharma Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹4.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jan 2025 | 101055050 | Others | ₹4.9 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Ripharma Laboratories Limited has 6 court cases on record: 6 filed against it. All cases are pending.
Total cases
6
Filed against the company
6
Pending
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 6 | 6 |
Cases on record (3 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Vardhaman Exports and 2 Ors. and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Vardhaman Exports and Ors. | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Vardhaman Exports and 2 Ors. | Pending |
To see the full case history of Ripharma Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ripharma Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ripharma Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR2686R1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ripharma Laboratories Limited, buy the company report.
Recent activity
Ripharma Laboratories Limited has 8 board changes on record since 2015: 6 appointments and 2 cessations. The latest: Shantilal Rajmal Jain was appointed as Director on 04 Feb 2025.
AGM
Ripharma Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ripharma Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Shantilal Rajmal Jain was appointed as Director.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 101055050 was registered on 23 Jan 2025.
Ceased
Champalal Rajmal Jain ceased to be Director.
Ceased
Shantilal Rajmal Jain ceased to be Director.
Appointed
Amit Shantilal Jain was appointed as Director.
Appointed
Milan Champalal Jain was appointed as Director.
Appointed
Rishabh Shreepal Jain was appointed as Director.
Appointed
Shreepal Champalal Jain was appointed as Director.
Appointed
Shrenik Champalal Jain was appointed as Director.
Incorporation
25 Mar 2015
Ripharma Laboratories Limited was registered on 25 Mar 2015 with Roc Mumbai & aged 11 years 7 months as per MCA records.
Frequently asked questions
Ripharma Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 March 2015 (11+ years old) and is registered under CIN U24100MH2015PLC262970.
Ripharma Laboratories has 6 current directors:
- Rishabh Shreepal Jain - Director
- Shantilal Rajmal Jain - Director
- Shreepal Champalal Jain - Director
- Shrenik Champalal Jain - Director
- Milan Champalal Jain - Director
- Amit Shantilal Jain - Director
The latest financial statements of Ripharma Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ripharma Laboratories is 27AAHCR2686R1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ripharma Laboratories is U24100MH2015PLC262970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ripharma Laboratories has 6 court cases on record: 6 filed against it. 6 are pending.
Ripharma Laboratories was incorporated on 25 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Shantilal Rajmal Jain was appointed as Director on 04 Feb 2025. Champalal Rajmal Jain ceased to be Director on 13 Feb 2024. Shantilal Rajmal Jain ceased to be Director on 16 Sep 2018. Ripharma Laboratories has 8 board changes on record in total.
Yes, Ripharma Laboratories is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0142146).
Ripharma Laboratories can be reached through the website ripharma.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages